Skip to main content

Ikarian Capital, LLC

Position in CAPR — Capricor Therapeutics, Inc.

CIK 1778253 DALLAS, TX

Position in CAPR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$16,051,656
-$629,856 QoQ
Shares Held
528,015
-8.7% QoQ
Ownership
0.912%
of shares outstanding
% of Portfolio
2.24%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CAPR Over Time

Shares Held

Position Value (USD)

Derivatives in CAPR

reported options exposure · as of Mar 31, 2026
CallValue
$10,640,000
CallShares
350,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Ikarian Capital, LLC holds $657,306,791 across 105 Biotechnology names. CAPR ranks #9 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CAPR

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,640,000 350,000
2026-03-31 $16,051,656 528,015
2025-12-31 $16,681,512 578,015
2025-09-30 $1,908,068 264,642
2025-09-30 $721,000 100,000
2025-09-30 $721,000 100,000
2025-06-30 $6,951,000 700,000
2025-06-30 $13,506,786 1,360,200
2025-03-31 $3,796,000 400,000
2024-12-31 $4,140,000 300,000
2024-12-31 $4,983,180 361,100
2024-09-30 $4,563,000 300,000
2024-09-30 $4,563,000 300,000
2024-09-30 $4,563,000 300,000